Literature DB >> 16825397

Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women.

Peter Lowe1, Peter O'Loughlin, Kathryn Evans, Michael White, Paul B Bartley, Renu Vohra.   

Abstract

The performance of the APTIMA Combo 2 assay (AC2) for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in urine samples was compared to that of the AMPLICOR CT/NG assay (AMP). The AC2 performance was superior to that of AMP for both organisms in this study.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16825397      PMCID： PMC1489522          DOI： 10.1128/JCM.00476-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002.

Authors:  Robert E Johnson; Wilbert J Newhall; John R Papp; Joan S Knapp; Carolyn M Black; Thomas L Gift; Richard Steece; Lauri E Markowitz; Owen J Devine; Cathleen M Walsh; Susan Wang; Dorothy C Gunter; Kathleen L Irwin; Susan DeLisle; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2002-10-18

2.  Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results.

Authors:  B Van Der Pol; D H Martin; J Schachter; T C Quinn; C A Gaydos; R B Jones; K Crotchfelt; J Moncada; D Jungkind; B Turner; C Peyton; J F Kelly; J B Weiss; M Rosenstraus
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Diagnostic performance of the Roche AMPLICOR PCR in detecting Neisseria gonorrhoeae in genitourinary specimens from female sex workers in Cotonou, Benin.

Authors:  L Mukenge-Tshibaka; M Alary; F Bernier; E van Dyck; C M Lowndes; A Guédou; S Anagonou; J R Joly
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

4.  Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae.

Authors:  D H Martin; C Cammarata; B Van Der Pol; R B Jones; T C Quinn; C A Gaydos; K Crotchfelt; J Schachter; J Moncada; D Jungkind; B Turner; C Peyton
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

5.  Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  B Boyadzhyan; T Yashina; J H Yatabe; M Patnaik; C S Hill
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation.

Authors:  Jeanne Moncada; Julius Schachter; Edward W Hook; Dennis Ferrero; Charlotte Gaydos; Thomas C Quinn; Dean Willis; Alice Weissfeld; David H Martin
Journal:  Sex Transm Dis       Date:  2004-05       Impact factor: 2.830

7.  Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay.

Authors:  S N Tabrizi; S Chen; M A Cohenford; B B Lentrichia; E Coffman; T Shultz; J W Tapsall; S M Garland
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

8.  Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.

Authors:  C A Gaydos; T C Quinn; D Willis; A Weissfeld; E W Hook; D H Martin; D V Ferrero; J Schachter
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Multicenter validation of the cppB gene as a PCR target for detection of Neisseria gonorrhoeae.

Authors:  S M Bruisten; G T Noordhoek; A J C van den Brule; B Duim; C H E Boel; K El-Faouzi; R du Maine; S Mulder; D Luijt; J Schirm
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors.

Authors:  S Chong; D Jang; X Song; J Mahony; A Petrich; P Barriga; M Chernesky
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948
View more
  10 in total

1.  Supplemental testing is still required in australia for samples positive for Neisseria gonorrhoeae by nucleic acid detection tests.

Authors:  G Lum; S M Garland; S Tabrizi; G Harnett; D W Smith; T P Sloots; D M Whiley; J W Tapsall
Journal:  J Clin Microbiol       Date:  2006-11       Impact factor: 5.948

2.  How reliable are tests for trachoma?--a latent class approach.

Authors:  Craig W See; Wondu Alemayehu; Muluken Melese; Zhaoxia Zhou; Travis C Porco; Stephen Shiboski; Bruce D Gaynor; John Eng; Jeremy D Keenan; Thomas M Lietman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-03       Impact factor: 4.799

3.  Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.

Authors:  Jeremy D Keenan; Craig W See; Jeanne Moncada; Berhan Ayele; Teshome Gebre; Nicole E Stoller; Charles E McCulloch; Travis C Porco; Bruce D Gaynor; Paul M Emerson; Julius Schachter; Thomas M Lietman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

4.  Description of an unusual Neisseria meningitidis isolate containing and expressing Neisseria gonorrhoeae-Specific 16S rRNA gene sequences.

Authors:  Marion Walcher; Rhonda Skvoretz; Megan Montgomery-Fullerton; Vivian Jonas; Steve Brentano
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

5.  Evaluation of Gen-Probe APTIMA-based Neisseria gonorrhoeae and Chlamydia trachomatis confirmatory testing in a metropolitan setting of high disease prevalence.

Authors:  Erik Munson; Vivian Boyd; Jolanta Czarnecka; Judy Griep; Brian Lund; Nancy Schaal; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

6.  Molecular Diagnosis of Sexually Transmitted Chlamydia trachomatis in the United States.

Authors:  April L Harkins; Erik Munson
Journal:  ISRN Obstet Gynecol       Date:  2011-06-12

7.  Point-of-care test for detection of urogenital chlamydia in women shows low sensitivity. A performance evaluation study in two clinics in Suriname.

Authors:  Jannie J van der Helm; Leslie O A Sabajo; Antoon W Grunberg; Servaas A Morré; Arjen G C L Speksnijder; Henry J C de Vries
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

8.  Efficient Detection of Pathogenic Leptospires Using 16S Ribosomal RNA.

Authors:  Brian T Backstedt; Ozlem Buyuktanir; Janet Lindow; Elsio A Wunder; Mitermayer G Reis; Sahar Usmani-Brown; Michel Ledizet; Albert Ko; Utpal Pal
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

9.  Effect and mechanisms of reproductive tract infection on oxidative stress parameters, sperm DNA fragmentation, and semen quality in infertile males.

Authors:  Kang-Sheng Liu; Xiao-Dong Mao; Feng Pan; Rui Fang An
Journal:  Reprod Biol Endocrinol       Date:  2021-06-28       Impact factor: 5.211

Review 10.  Diagnosis of Chlamydia trachomatis genital infections in the era of genomic medicine.

Authors:  Seema Shetty; Christina Kouskouti; Uwe Schoen; Nikolaos Evangelatos; Shashidhar Vishwanath; Kapaettu Satyamoorthy; Franz Kainer; Angela Brand
Journal:  Braz J Microbiol       Date:  2021-06-23       Impact factor: 2.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.